CONFAB DIMENHYDRINATE 100 MG SUPPOSITORY Canada - English - Health Canada

confab dimenhydrinate 100 mg suppository

laboratoires confab inc - dimenhydrinate - suppository - 100mg - dimenhydrinate 100mg - antihistamines

DRAXXIN KP SOLUTION Canada - English - Health Canada

draxxin kp solution

zoetis canada inc - tulathromycin; ketoprofen - solution - 100mg; 120mg - tulathromycin 100mg; ketoprofen 120mg - cattle

DRAXXIN KP- tulathromycin and ketoprofen injection injection, solution United States - English - NLM (National Library of Medicine)

draxxin kp- tulathromycin and ketoprofen injection injection, solution

zoetis inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422), ketoprofen (unii: 90y4qc304k) (ketoprofen - unii:90y4qc304k) - draxxin® kp is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis , and control of pyrexia associated with brd in beef steers, beef heifers, beef calves 2 months of age and older, beef bulls, dairy bulls, and replacement dairy heifers. not for use in reproducing animals over one year of age, dairy calves, or veal calves. the use of draxxin kp injection is contraindicated in animals previously found to be hypersensitive to tulathromycin and ketoprofen. not for human use. keep out of reach of children. the safety data sheet (sds) provides more detailed occupational safety information. to obtain a safety data sheet contact zoetis inc. at 1-888-963-8471.

KP SLEDLYN COUGH EXPECTORANT (OTC) Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

kp sledlyn cough expectorant (otc)

diphenhydramine hcl 15mg, ammonium chloride bp 100mg, sodium citrate bp 40mg, menthol bp 1mg

KP G4 /Focus - Neurophysiologic monitoring system Australia - English - Department of Health (Therapeutic Goods Administration)

kp g4 /focus - neurophysiologic monitoring system

natus medical pty ltd - 46566 - neurophysiologic monitoring system - to be used as an electrophysiology recording device via external recording electrodes attached to the patient's skin

APLACE Tablets 100mg (アプレース錠100mg) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

aplace tablets 100mg (アプレース錠100mg)

kyorin pharmacetical co.,ltd - troxipide - white tablet, diameter: 8.1mm, thickness: 4.1mm

Cytarabine 100 mg/ml Solution for Injection or Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

cytarabine 100 mg/ml solution for injection or infusion

fresenius kabi oncology plc - cytarabine - solution for injection/infusion - 100 milligram(s)/millilitre - pyrimidine analogues; cytarabine

CASPOFUNGIN KP caspofungin (as acetate) 70 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

caspofungin kp caspofungin (as acetate) 70 mg powder for injection vial

amneal pharma australia pty ltd - caspofungin acetate, quantity: 77.7 mg (equivalent: caspofungin, qty mg) - injection, powder for - excipient ingredients: mannitol; sucrose; sodium hydroxide; hydrochloric acid - caspofungin kp is indicated for:,? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics,? treatment of:,-invasive candidiasis, including candidaemia,-oesophageal candidiasis,-invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

CASPOFUNGIN KP caspofungin (as acetate) 50 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

caspofungin kp caspofungin (as acetate) 50 mg powder for injection vial

amneal pharma australia pty ltd - caspofungin acetate, quantity: 55.5 mg (equivalent: caspofungin, qty 50 mg) - injection, powder for - excipient ingredients: sodium hydroxide; mannitol; sucrose; hydrochloric acid - caspofungin kp is indicated for:,? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics,? treatment of:,-invasive candidiasis, including candidaemia,-oesophageal candidiasis,-invasive aspergillosis in patients who are refractory to or intolerant of other therapies.